Prevalence of Failure due to Adverse Reaction to Metal Debris in Modern, Medium and Large Diameter Metal-on-Metal Hip Replacements – The Effect of Novel Screening Methods: Systematic Review and Metaregression Analysis
Open Access
- 1 March 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (3) , e0147872
Abstract
Metal-on-metal (MoM) hip replacements were used for almost a decade before adverse reactions to metal debris (ARMD) were found to be a true clinical problem. Currently, there is a paucity of evidence regarding the usefulness of systematic screening for ARMD. We implemented a systematic review and meta-analysis to establish the prevalence of revision confirmed ARMD stratified by the use of different screening protocols in patients with MoM hip replacements. Five levels of screening were identified: no screening (level 0), targeted blood metal ion measurement and/or cross-sectional imaging (level 1), metal ion measurement without imaging (level 2), metal ion measurement with targeted imaging (level 3) and comprehensive screening (both metal ions and imaging for all; level 4). 122 studies meeting our eligibility criteria were included in analysis. These studies included 144 study arms: 100 study arms with hip resurfacings, 33 study arms with large-diameter MoM total hip replacements (THR), and 11 study arms with medium-diameter MoM THRs. For hip resurfacing, the lowest prevalence of ARMD was seen with level 0 screening (pooled prevalence 0.13%) and the highest with level 4 screening (pooled prevalace 9.49%). Pooled prevalence of ARMD with level 0 screening was 0.29% and with level 4 screening 21.3% in the large-diameter MoM THR group. In metaregression analysis of hip resurfacings, level 4 screening was superior with regard to prevalence of ARMD when compared with other levels. In the large diameter THR group level 4 screening was superior to screening 0,2 and 3. These outcomes were irrespective of follow-up time or study publication year. With hip resurfacings, routine cross-sectional imaging regardless of clinical findings is advisable. It is clear, however, that targeted metal ion measurement and/or imaging is not sufficient in the screening for ARMD in any implant concepts. However, economic aspects should be weighed when choosing the preferred screening level.Keywords
This publication has 139 references indexed in Scilit:
- The outcomes of hip resurfacing compared to standard primary total hip arthroplasty in MenBMC Musculoskeletal Disorders, 2013
- Do Survival Rate and Serum Ion Concentrations 10 Years After Metal-on-Metal Hip Resurfacing Provide Evidence for Continued Use?Clinical Orthopaedics and Related Research, 2012
- High Revision Rate at 5 Years after Hip Resurfacing with the Durom ImplantClinical Orthopaedics and Related Research, 2011
- What is the Midterm Survivorship and Function After Hip Resurfacing?Clinical Orthopaedics and Related Research, 2010
- Indications and results of hip resurfacingInternational Orthopaedics, 2010
- Failed Metal-on-Metal Hip Arthroplasties: A Spectrum of Clinical Presentations and Operative FindingsClinical Orthopaedics and Related Research, 2010
- Reduced Articular Surface of One-piece Cups: A Cause of Runaway Wear and Early FailureClinical Orthopaedics and Related Research, 2010
- Birmingham hip resurfacing: Five to eight year resultsInternational Orthopaedics, 2010
- Metal-on-Metal Hip Arthroplasty: Does Early Clinical Outcome Justify the Chance of an Adverse Local Tissue Reaction?Clinical Orthopaedics and Related Research, 2010
- Outcome of Hip Resurfacing Arthroplasty in Patients with Developmental Hip DysplasiaClinical Orthopaedics and Related Research, 2008